Literature DB >> 28933371

The Evolution of Pediatric Disease-A Moving Target in Public Health.

Mark A Brown1,2,3,4.   

Abstract

There is a growing threat in the re-emergence of diseases that impact pediatric demographics. While major strides have been made in the field of childhood cancers, there are still more questions than answers. In addition, public resistance to recommended practices related to childhood vaccinations fueled by misinformation has allowed infectious diseases to resurface in developed nations. Meanwhile, climate change and other destabilizing factors are shifting vector populations and driving the emergence of new diseases. Herein we call upon the community of human health researchers to confront the evolving specter of pediatric disease.

Entities:  

Keywords:  childhood vaccination; emerging infectious disease; pediatric

Year:  2017        PMID: 28933371      PMCID: PMC5622334          DOI: 10.3390/diseases5030018

Source DB:  PubMed          Journal:  Diseases        ISSN: 2079-9721


1. Introduction

The idea that deadly infectious diseases have been all but eradicated has receded with the emergence of new threats over recent decades such as HIV and hanta virus pulmonary syndrome [1,2]. Figure 1 provides examples of emerging infectious diseases of the past fifty years. Likewise, the failure of parents to follow recommended vaccination guidelines as a result of misguided fear related to the safety of vaccines has resulted in the re-emergence of previously well controlled childhood illnesses such as pertussis [3] and measles [4]. Worldwide, infectious diseases remain a leading cause of death among children.
Figure 1

Emerging infectious diseases of the past fifty years.

Similar to progress with infectious diseases, enormous strides have been made in the diagnosis and clinical management of childhood cancers. Although deaths from cancer have decreased by over 70% in the last 40 years, cancer continues to be the leading cause of death associated with childhood disease [5]. This year, it is estimated that over 10,000 new cases of cancer will be diagnosed in children under the age of 15 in the United States, alone [5]. In the field of pediatric oncology, leukemias and brain tumors represent a major crisis and bottleneck for preventable childhood deaths. Figure 2 illustrates the prevalence of the most common forms of pediatric cancer.
Figure 2

Childhood Cancers.

Beyond infectious diseases and cancer, a host of other maladies impact pediatric demographics. These range from acute, life-threatening conditions to chronic diseases which impact quality of life and/or projected lifespan. Common chronic childhood diseases include asthma, diabetes, obesity, and cystic fibrosis, to name a few.

2. Discussion

Despite great progress in the many sub-disciplines of pediatric disease, children are exposed to some of the most painful, debilitating, and deadly diseases. As human health researchers, we have the ability and the obligation to help change this. We encourage the pediatric health research community to come together and share recent findings in an upcoming Special Issue of Diseases titled, “Pediatric Diseases.” In this Special Issue, we invite papers related to detection, prevention, diagnosis and treatment of human pediatric diseases. Papers related to molecular mechanisms, epidemiology, immunology, and public health initiatives associated with pediatric diseases are also encouraged. For more information, visit: http://www.mdpi.com/journal/diseases/special_issues/pediatric_diseases.
  3 in total

1.  Emerging and reemerging infectious diseases: the perpetual challenge.

Authors:  Anthony S Fauci
Journal:  Acad Med       Date:  2005-12       Impact factor: 6.893

2.  [Pertussis: a reemerging infection?].

Authors:  B Kriz; K Fabiánová; M Maixnerová; C Benes; M Malý
Journal:  Epidemiol Mikrobiol Imunol       Date:  2007-04       Impact factor: 0.444

Review 3.  When an emerging disease becomes endemic.

Authors:  Graham F Medley; Anna Vassall
Journal:  Science       Date:  2017-07-14       Impact factor: 47.728

  3 in total
  1 in total

1.  Facilitating a More Efficient Commercial Review Process for Pediatric Drugs and Biologics.

Authors:  Ryan D Rykhus; Zachary V Shepard; Alix Young; Hadley Frisby; Kailee A Calder; Collin M Coon; Justin A Falk; Sydney R McAndrews; Aspen Turner; Christina Chang; Johanna Michelsohn; Raegan Petch; Sarah M Dieker; Benjamin H Markworth; Kevin Alamo-Perez; Aaron J Hosack; Jacob M Berg; Christian Schmidt; Joachim Storsberg; Mark A Brown
Journal:  Diseases       Date:  2017-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.